Category: Defective Drugs

Pfizer is recalling batches of its anti-smoking drug Chantix after an increased level of impurities that can cause cancer were discovered in the medication.

According to a report on People.com, the nationwide recall includes two lots of Chantix 0.5 mg tablets, two lots of Chantix 1 mg tablets and eight lots of a Chantix kit of 0.5 mg/1 mg tablets.

Prolonged ingestion of the discovered impurities can result in serious long term damage and drastic side effects. …Read the rest »

Avet Pharmaceuticals recalled eight lots of tetracycline antibiotics under the Heritage brand because the medication can fail to dissolve or effectively treat an infection. According to an alert issued by the U.S. Food and Drug Administration (FDA), when these medications fail to work, it could result in severe pneumonia or even death. Included in this recall are eight lots of tetracycline HCI capsules USP in 100-count bottles of 250-mg and 500-mg dosages. …Read the rest »

The U.S. Food and Drug Administration (FDA) is asking all manufacturers to pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately. According to a report in The New York Times, the levels of a contaminant in the heartburn medications increase over time and can progress to cancer when stored at higher than normal temperatures. …Read the rest »

The Food and Drug Administration (FDA) is looking into whether Metformin, a drug that is commonly used to treat type 2 diabetes contains a probable carcinogen, which was recalled abroad. According to a KTLA news report, health officials are investigating whether Metformin sold in the United States contains NDMA, a contaminant that has been linked to cancer. …Read the rest »

The U.S. Food and Drug Administration has issued a safety alert indicating three drugs used to treat some patients with advanced breast cancer may cause severe lung inflammation. According to news reports, all three therapies – palbociclib (Ibrance, Pfizer), ribociclib (Kisqali, Novartis) and abemaciclib (Verzenio, Eli Lilly) – are cyclin dependent kinase 4/6 inhibitors. The federal agency approved adding warnings to prescribing information and patient package insert for the entire class of CDK 4/6 inhibitors. …Read the rest »

A baby cough syrup sold at Dollar General stores nationwide has been recalled because of a possible bacterial contamination. According to a CBS news report, Kingston Pharma LLC, which manufactures the “DG/health NATURALS baby Cough Syrup + Mucus” says the medicine may be tainted with Bacillus cereus/Bacillus circulans. This is a type of bacteria that has the potential to cause gastrointestinal illness and symptoms such as vomiting and diarrhea. The U.S. Food and Drug Administration (FDA) says the symptoms are often mild although more serious and even fatal cases have occurred. …Read the rest »

The Food and Drug Administration (FDA) has announced a renewed effort to hold retailers accountable for selling e-cigarettes to children and teenagers as part of its campaign against youth vaping. According to a news report on Time.com, e-cigarettes are not legally available to anyone under the age of 18 in the United States. Still, use of these devices by youth is widely prevalent nationwide. …Read the rest »

The recall of infant liquid ibuprofen sold at large retailers such as CVS and Wal-Mart, has been expanded over concerns over toxicity. According to an NBC News report, the drug manufacturer Tris-Pharma, said that additional lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 ml, sold in 0.5-ounce bottles at CVS, Wal-Mart and Family Dollar Services may have higher concentrations of ibuprofen than what’s on the label. Routine tests found that some units contained 10 percent more ibuprofen than specified levels. …Read the rest »

The U.S. Food and Drug Administration (FDA) is reexamining the safety of Nuplazid, a drug that was approved in spite of concerns that not enough was known about its risks. According to a CNN news report, the FDA is re-examining the medication, which is the only drug approved to treat hallucinations and delusions associated with Parkinson’s disease psychosis. The medication has been cited as a “suspect” is hundreds of deaths voluntarily reported by caregivers, doctors and other medical professionals since it hit the market. …Read the rest »

The U.S. Food and Drug Administration (FDA) has issued a warning letter to a New Jersey based company, which recently recalled homeopathic teething tablets for infants and toddlers with inconsistent levels of belladonna, a toxic herb. According to a report in the Daily Hornet, the FDA sent Raritan Pharmaceuticals a warning letter on June 20, 2017 for manufacturing violations involving homeopathic teething tablets containing belladonna, which have been responsible for several child deaths. …Read the rest »